Shares of Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) have been assigned an average recommendation of “Buy” from the six brokerages that are presently covering the company, MarketBeat Ratings reports. Five investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $61.20.
ASTH has been the topic of several recent analyst reports. Truist Financial raised their price objective on Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a research note on Friday, August 9th. Stifel Nicolaus raised their target price on Astrana Health from $48.00 to $60.00 and gave the company a “buy” rating in a research report on Thursday, August 1st. Robert W. Baird boosted their price target on shares of Astrana Health from $54.00 to $67.00 and gave the stock an “outperform” rating in a report on Thursday, August 15th. Finally, BTIG Research boosted their target price on shares of Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research note on Thursday.
Check Out Our Latest Stock Analysis on ASTH
Astrana Health Stock Up 1.4 %
Astrana Health (NASDAQ:ASTH – Get Free Report) last issued its quarterly earnings data on Wednesday, August 7th. The company reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.01. The firm had revenue of $486.30 million during the quarter, compared to analyst estimates of $440.68 million. Astrana Health had a return on equity of 10.71% and a net margin of 4.30%. The company’s revenue for the quarter was up 39.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.28 EPS. As a group, sell-side analysts forecast that Astrana Health will post 1.33 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Astrana Health stock. Central Pacific Bank Trust Division purchased a new position in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,753 shares of the company’s stock, valued at approximately $160,000. 52.77% of the stock is owned by institutional investors.
About Astrana Health
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Featured Articles
- Five stocks we like better than Astrana Health
- 3 Warren Buffett Stocks to Buy Now
- 3 Oversold Stocks with Big RSI Rebound Potential
- Using the MarketBeat Stock Split Calculator
- Joby Aviation Soars With Toyota Investment and Analyst Support
- What Investors Need to Know About Upcoming IPOs
- 3 Stocks Set to Benefit from Cooling Inflation Trends
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.